All posts by: SetPoint Medical (Admin)

About SetPoint Medical (Admin)

FDA Approves Investigational Device Exemption for SetPoint Bioelectronic Therapy Clinical Study in Rheumatoid Arthritis

  Valencia, CA – December 11, 2017 – SetPoint Medical, a clinical-stage biomedical technology company developing an implantable bioelectronic medicine therapy for chronic inflammatory diseases, has received Investigational Device Exemption (IDE) approval from the U.S. Food & Drug Administration (FDA) to initiate a pilot trial in the U.S. for patients with drug refractory rheumatoid arthritis … Continue reading

SetPoint Medical Presents Early Data Showing Bioelectronic Medicine Accelerates Remyelination in Animal Model of Multiple Sclerosis

  – Data Presented at ECTRIMS-ACTRIMS Multiple Sclerosis Meeting in Paris – Valencia, CA – October 30, 2017 – SetPoint Medical, a clinical-stage biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, presented positive data from a study exploring the therapeutic effects of a bioelectronic medicine approach for multiple sclerosis (MS) showing that … Continue reading

SetPoint Secures $30 Million Series D Equity Financing

  – Funding supports clinical momentum; enables upcoming phase 2 trial in rheumatoid arthritis – Valencia, CA – August 28, 2017 – SetPoint Medical, a clinical-stage biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, announced today that it has secured $30 million in Series D equity financing. The Series D financing will … Continue reading

SetPoint Medical Appoints Terry Bevirt as VP of Clinical Affairs

  – Deep Expertise Will Guide SetPoint Bioelectronic Medicine Platform Clinical Programs – Valencia, CA  – July 31, 2017 – SetPoint Medical, a clinical-stage biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, announced today the appointment of Terry Bevirt as Vice President of Clinical Affairs. Ms. Bevirt brings more than 20 years … Continue reading

SetPoint Medical Appoints David Chernoff, MD as Chief Medical Officer

  – Brings Clinical Leadership as SetPoint Advances its Bioelectronic Medicine Platform – Valencia, CA  – June 15, 2017 – SetPoint Medical, a clinical-stage biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, announced today the appointment of David Chernoff, MD as Chief Medical Officer. Dr. Chernoff is a molecular diagnostics and biopharmaceutical … Continue reading